Jonathan Macquitty News Today

Jonathan MacQuitty talks about cell and gene therapy shortcomings and the challenges for private companies at different funding stages in 2023.

24.03.2022 - Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that Karin Eastham has been appointed as Personalis’ new Board Chair effective as of Personalis’ Annual Meeting of Stockholders on May 17, 2022. ... Seite 1

Healthtech Veteran Steve Schwartz Joins Freespira Board Former Livongo, 23andMe, Allscripts, Healthways and LabCorp leader brings unique expertise to digital therapeutic company News provided by Share this article Share this article KIRKLAND, Wash., March 16, 2021 /PRNewswire/ -- Freespira, Inc., maker of the first FDA-cleared digital therapeutic to significantly reduce or eliminate symptoms of panic attacks, panic disorder and post-traumatic stress disorder (PTSD) in only 28 days, announced t...

Press release content from Business Wire. The AP news staff was not involved in its creation. Personalis Announces Changes to its Board of Directors March 8, 2021 GMT MENLO PARK, Calif.--(BUSINESS WIRE)--Mar 8, 2021-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, today announced that it has appointed Dr. Woodrow (Woody) Myers to its Board of Directors and to the Nominating and Corporate Governance Committee of the Board. The company also an...